Why is a dose of 75–100 mg of nortriptyline required for treating chronic headaches, when low‑dose tricyclics are sometimes used, and isn’t that dose typically reserved for depression and anxiety?

Nortriptyline Dosing for Chronic Headache Prevention

The 75–100 mg dose range for nortriptyline in chronic headache prevention is NOT the standard starting point—most patients actually respond to much lower doses (10–50 mg), which are well below the typical antidepressant range of 75–150 mg. The confusion arises because guidelines cite a "goal dose" of 75–150 mg for tricyclic antidepressants (TCAs) in headache prevention, but real-world practice and recent evidence show that lower doses are often effective and better tolerated 1, 2.

Understanding the Dose-Response Relationship

Analgesic vs. Antidepressant Effects

The key distinction is that TCAs work for headache prevention through mechanisms independent of their antidepressant activity 3:

• Analgesic doses are typically lower than those required for depression treatment
• The onset of analgesic action occurs earlier than antidepressant effects
• Effective headache prevention often occurs at 30–75 mg daily, whereas depression treatment typically requires 75–150 mg 3, 4

Evidence-Based Dosing Patterns

Recent real-world data contradicts the higher dose recommendations:

• A 2016 retrospective study of 178 headache patients found that 63% were started on just 10 mg daily, with most patients taking only 10–25 mg at maximum dose 5
• 75% of patients improved on these low doses, with 85% still taking the medication at follow-up 5
• A 2010 meta-analysis confirmed TCAs are effective for headache prevention, with effectiveness increasing over time rather than with higher doses 6

Guideline Recommendations vs. Clinical Practice

What Guidelines Actually Say

The 2010 Mayo Clinic neuropathic pain guidelines recommend 2:

• Starting dose: 25 mg at bedtime
• Titration: Increase by 25 mg every 3–7 days as tolerated
• Maximum dose: 150 mg/day (if blood levels of active drug + metabolite <100 ng/mL)
• Trial duration: 6–8 weeks with at least 2 weeks at maximum tolerated dose

The 2024 cyclic vomiting syndrome guideline lists a goal dose of 75–150 mg for TCAs 1, but this represents an upper target range, not a required dose.

The Reality Gap

Most patients never reach—and don't need—these higher doses:

• A 1997 pain clinic survey found that 73% of patients were treated with low doses (≤50 mg amitriptyline equivalent) and only 12% received full doses (≥150 mg) 7
• Even when patients had neither side effects nor optimal response, doses remained low 7
• Amitriptyline and doxepin appeared more effective than other TCAs, but also caused more side effects leading to dose limitation 7

Practical Dosing Algorithm

Starting and Titrating Nortriptyline

1. Initial dose: 10–25 mg at bedtime 2, 8

   • Start at 10 mg for elderly patients or those sensitive to medications
   • Nortriptyline has fewer anticholinergic effects than amitriptyline 3, 2

2. Titration schedule:

   • Increase by 10–25 mg every 3–7 days as tolerated 2
   • Slow titration is better tolerated than rapid escalation 1
   • Most patients respond to 25–75 mg daily 3, 4, 5

3. When to stop titrating:

   • Adequate headache reduction achieved (≥50% reduction in frequency/severity)
   • Intolerable side effects develop
   • Maximum dose of 150 mg reached 2
   • Give each dose level 2–3 weeks before increasing 2

4. Trial duration: 6–8 weeks minimum, with at least 2 weeks at the maximum tolerated dose 2

Why Not Everyone Needs 75–100 mg

A 2025 study comparing nortriptyline (10–40 mg) to lifestyle modifications found:

• Nortriptyline at maximum 40 mg effectively alleviated vestibular migraine symptoms 9
• 88% of patients reported quality of life improvement 9
• This demonstrates efficacy well below the traditional 75–150 mg range

Common Pitfalls and Caveats

Side Effects Limit Dose Escalation

The most common adverse effects are dose-dependent 1, 3, 8:

• Somnolence and sedation (can be beneficial for comorbid insomnia)
• Dry mouth, blurred vision, constipation
• Weight gain
• Prolonged QTc on ECG (obtain screening ECG in patients >40 years) 2

Nortriptyline is better tolerated than amitriptyline due to fewer anticholinergic and antihistaminergic effects 1, 3, making it the preferred secondary-amine TCA.

When Higher Doses May Be Needed

Consider doses approaching 75–150 mg when 2:

• Lower doses (25–50 mg) have been tried for adequate duration without benefit
• Patient has comorbid depression requiring antidepressant-level dosing
• Therapeutic drug monitoring shows subtherapeutic levels (<100 ng/mL combined nortriptyline + 10-hydroxynortriptyline) 2

Special Populations

Elderly patients 8:

• Start with lower doses (10 mg)
• Titrate more slowly
• Higher plasma concentrations of active metabolite (10-hydroxynortriptyline) occur in elderly 8
• Increased risk of confusion, falls, and anticholinergic effects

Patients with cardiac disease 2:

• Limit doses to <100 mg/day when possible
• Monitor for cardiac conduction abnormalities
• TCAs can cause cardiac toxicity, especially at higher doses

The Bottom Line

The 75–100 mg dose range represents a traditional "goal dose" from older guidelines, but modern evidence and clinical practice demonstrate that most patients with chronic headaches respond to much lower doses (10–50 mg). Start low (10–25 mg), titrate slowly based on response and tolerability, and recognize that many patients achieve adequate headache control well below antidepressant-level dosing. The analgesic mechanism operates independently of antidepressant effects, allowing effective headache prevention at doses that minimize side effects and improve medication persistence 3, 6, 5.